{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:40Z","timestamp":1786988140884,"version":"build-2736575974"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejpn.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T07:01:19Z","timestamp":1394780479000},"page":"536-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A serial 18FDG-PET study of a patient with SSPE who had good prognosis by combination therapy with interferon alpha and ribavirin"],"prefix":"10.1016","volume":"18","author":[{"given":"Takashi","family":"Ohya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushiro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuhiko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetsugu","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nagamitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyojiro","family":"Matsuishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2014.03.001_bib1","series-title":"Pediatric neurology: principles and practice","first-page":"671","author":"Swaiman","year":"1999"},{"key":"10.1016\/j.ejpn.2014.03.001_bib2","first-page":"A430","article-title":"Intraparenchymal alpha interferon and intraventricular ribavirin for subacute sclerosing panencephalitis (SSPE)","volume":"54","author":"Stephen","year":"2000","journal-title":"Neurol (suppl.)"},{"key":"10.1016\/j.ejpn.2014.03.001_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0387-7604(03)00062-7","article-title":"Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan","volume":"25","author":"Tomoda","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.ejpn.2014.03.001_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF00256553","article-title":"Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography","volume":"13","author":"Yanai","year":"1987","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.ejpn.2014.03.001_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00833917","article-title":"Changing patterns of glucose metabolism during the course of subacute sclerosing panencephalitis as measured with 18FDG-positron-emission tomography","volume":"239","author":"Huber","year":"1992","journal-title":"J Neurol"},{"key":"10.1016\/j.ejpn.2014.03.001_bib6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/RLU.0b013e3181e9fa5f","article-title":"A correlative study of FDG PET, MRI\/CT, electroencephalography, and clinical features in subacute sclerosing panencephalitis","volume":"35","author":"Yilmaz","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejpn.2014.03.001_bib7","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/j.1365-2893.2011.01510.x","article-title":"Cerebral microglial activation in patients with hepatitis C: in\u00a0vivo evidence of neuroinflammation","volume":"19","author":"Grover","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejpn.2014.03.001_bib8","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.57.11.1601","article-title":"Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings","volume":"57","author":"von Giesen","year":"2000","journal-title":"Arch Neurol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814000415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379814000415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T23:52:10Z","timestamp":1538783530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379814000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1090379814000415"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.03.001","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A serial 18FDG-PET study of a patient with SSPE who had good prognosis by combination therapy with interferon alpha and ribavirin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2014.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}